In this section
Clinical trials
- Participate in a clinical trial
- For medical professionals
- Active clinical trials for pediatric cancers
- CAR-20/19-T cells in pediatric and young adult patients with relapsed/refractory B Cell Acute Lymphoblastic Leukemia (CAR-20/19-T) phase 1 clinical trial
- Unrelated and partially matched related donor peripheral stem cell transplantation for patients with hematologic malignancies clinical trial
- Early stage research
Active clinical trials
Cancer Clinical Trials - IIT-NEWMAN-ECTP
Protocol Summary
- Protocol No
- IIT-NEWMAN-ECTP
- Principal Investigator
- Amy Newman
- Phase
- N/A
- Title
- Communication in the Early Pediatric Cancer Treatment Period
- Associated Disease(s)
-
Late Effects and Supportive Studies
- Description (Summary)
- The purpose of this study is to provide a rich description of the communication that occurs among parents, children with ALL and clinicians and the barriers to effective communication during the early cancer treatment period.
- Participating Institutions
- Childrens Hospital of Wisconsin
- ClinicalTrials.gov
Contact us
For more information about cancer and blood disorders clinical trials, email us or call
(414) 955-4727
Get a second opinion
It's important to know what your options are. We can provide expert opinions to verify or give more information about an initial diagnosis. Contact us today.
Why participate in clinical trials?
"The steady improvement in survival for children with cancer is a direct result of their enrollment onto clinical trials; without which we would remain decades behind in terms of scientific advances in pediatric cancer." ~Michael J. Burke, MD